XClose

Division of Infection and Immunity

Menu

Flu003 Plus and Genomics

Respiratory Virus Hospitalisation Study (Flu003 Plus)

Summary

This international observational study aims to characterise adults who are hospitalised with influenza or other targeted respiratory viruses. The study is funded by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) and is being carried out by the International Network for Strategic Initiatives in Global HIV trials.

The study is a collaboration with four International Coordinating Centers (ICCs) of the INSIGHT network:

  • Copenhagen HIV Programme (CHIP) - Copenhagen, Denmark
  • Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL)
  • The Kirby Institute, University of New South Wales - Sydney, Australia
  • The Institute for Clinical Research at the Veterans Affairs Medical Center - Washington, D.C., USA.

It is important to better understand the characteristics of people with influenza who do not do well. The results of this study will be used to advise on the management of patients who are hospitalised with the flu or other viral respiratory infections. Patient involvement involves Nasopharyngeal and throat swabs of flu positive patients. 

Collaborators

Professor Robert Heyderman (Principle Investigator)
University College London